Boston, USA * June. 16 - 19

Milan, Italy * Mar. 17 - 19

Pharmacology Research & Perspectives , vol. 13, 1. https://doi.org/10.1002/prp2.70052 "Intravitreal Administration of Avacincaptad Pegol...

San Francisco, USA * Jan. 13 - 16

Stockholm, Sweden * Nov. 4 - 6

Yokohama, Japan * Oct. 9 - 11

"Lysophosphatidic Acid Receptor Subtype-1 Antagonist PIPE-791 Reduces Neuropathic Pain in Macaques" No. TH700 / 08 August 2024 / 9:30 AM...

創新藥物開發 Taipei, Taiwan HPR is pleased to participate with Mithra Biotechnology and CMIC Group in a symposium related to preclinical drug...

Evaluation of brain activation related to resting pain using functional magnetic resonance imaging in cynomolgus macaques undergoing knee...

Regenerative effects of platelet-rich plasma releasate injection in rabbit discs degenerated by intradiscal injection of condoliase |...

We hereby announce that Hamamatsu Pharma Research, Inc. has joined as a subsidiary company of CMIC HOLDINGS Co., Ltd. Notice Concerning...

Potential sex differences in activation of pain-related brain regions in nonhuman primates with a unilateral spinal nerve ligation Murata...

UPDATED: Dr. Liston featured in Stroke's Spotlight. Dr. Ted Liston et al.'s 2022 Stroke publication garnered 3rd place, American Heart...

*UPDATED*: Cover art for November 2022 issue (Vol. 4, Issue 11). Announcing publication of "Regional brain activation during rectal...

HPR announces publication of a brain imaging study in a NHP model of unilateral neuropathy.

Neuroprotective effect of brimonidine in a NHP model of ocular hypertension.

Announcing Astrocyte Pharmaceuticals' efficacy study of AST-004 in a NHP model of stroke! For more details, click here

HPR's first paper about a macaque model of ulcerative colitis in 2020 is now open to everyone! Click and check the paper